Fundz
Funding, M&A and exec moves matched to your market, guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Cipla merges with subsidiary Inzpera Health Sciences

RECENTLY ACQUIREDAug 19, 2026about 6 hours ago

Acquiring Company

Cipla

Acquired Company

Inzpera Health Sciences Limited

MumbaiManufacturingBiotechnologyHealth CarePharmaceuticalpharmaceuticalsManufacturingBiotechnologyHealth Care

Description

Cipla has completed its merger with Inzpera Health Sciences Limited, a wholly owned subsidiary. This merger aims to improve resource utilization, achieve economies of scale, and enhance shareholder value through better integration. The consolidation is expected to streamline business processes and reduce compliance costs.

Company Information

Company

Cipla

Location

Ganpatrao Kadam Marg

Mumbai, Maharashtra, India

About

Cipla is a global pharmaceutical company based in India. The company specializes in the production and distribution of a wide range of medications, including generic and branded drugs. Cipla is committed to providing accessible healthcare solutions and has a presence in many international markets.

Don't miss Cipla's next move

Get an email the moment Cipla makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Umang
Senior decision-maker at this company
••••••••@••••••••

See Umang's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Cipla's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Inzpera Health Sciences Limited?

Inzpera Health Sciences Limited was acquired by Cipla, based in Mumbai. The deal was reported on August 19, 2026. Cipla is a global pharmaceutical company based in India. The company specializes in the production and distribution of a wide range of medications, including generic and branded drugs. Cipla is privately held and operates in Manufacturing.

When did Cipla acquire Inzpera Health Sciences Limited?

Cipla's acquisition of Inzpera Health Sciences Limited was reported on August 19, 2026. Cipla has completed its merger with Inzpera Health Sciences Limited, a wholly owned subsidiary. This merger aims to improve resource utilization, achieve economies of scale, and enhance shareholder value through better integration. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Inzpera Health Sciences Limited do?

Inzpera Health Sciences Limited is a wholly owned subsidiary of Cipla that focuses on the development and commercialization of pharmaceutical products. It aims to enhance synergies within Cipla for better manufacturing and marketing. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.